Hair Relaxer Litigation Trial Set for September 2027
A federal judge scheduled the first bellwether trial for hair relaxer cancer litigation to begin on September 9, 2027.
Updated on Sept. 30, 2026 in Cancer
Live Poll
Should large corporations be held liable for health risks linked to their personal care products?
Judge Mary M. Rowland has set the start date for the first bellwether trial in the multidistrict litigation linking chemical hair relaxers to ovarian, endometrial, and uterine cancer. The trial, which focuses on products from L'Oreal USA Inc., is scheduled for September 9, 2027.
Why it matters
The outcome of these bellwether trials will help establish legal precedents and evaluate the strength of claims linking chemical hair products to serious health conditions. This process helps determine potential settlement structures for thousands of similar lawsuits.
The court selected 10 representative test cases to serve as the bellwether trial pool. This selection process, completed in April 2026, aims to provide a baseline for the broader multidistrict litigation.
The players
Mary M. Rowland
She is a United States District Judge for the Northern District of Illinois who oversees the ongoing multidistrict litigation.
L'Oreal USA Inc.
This entity is a major beauty and consumer goods company named as a defendant in the first bellwether trial case.
The details
Judge Mary M. Rowland, overseeing the litigation in the Northern District of Illinois, issued the docket entry finalizing the September trial date. The cases consolidate allegations that chemical hair straighteners and relaxers contributed to uterine, endometrial, and ovarian cancers.
Timeline
April 2026: Judge selected 10 bellwether trial cases.
September 24, 2026: Judge issued docket entry ordering trial.
January 28, 2027: Case management conferences begin.
September 9, 2027: First bellwether trial begins.
The Big Picture
This case follows the standard procedural path established by the multidistrict litigation (MDL) process. The scheduling of the bellwether trial follows the established procedural pattern of the multidistrict litigation process.
Individuals involved in the litigation should prepare for the upcoming January 2027 case management conferences. These proceedings establish the timeline for evidence presentation and potential resolution for affected claimants.
The takeaway
The court-mandated schedule provides a clear timeline for the litigation process as it moves toward its first test trial. Claimants and stakeholders should monitor the upcoming 2027 conferences for further updates on evidence proceedings.
What happens next
A series of case management conferences are scheduled to begin on January 28, 2027.
Further reading
For more information on legal and health developments, visit the Cancer section.
Source note: This article includes information reported by Harrismartin.
Live Poll
Should large corporations be held liable for health risks linked to their personal care products?
